Cellebrite DI Ltd. Class A Ordinary Shares
Here’s whether Cellebrite DI Ltd. Class A Ordinary Shares (CLBT) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.24% over 10 days); RSI 28 — oversold; weak 1-year return of -30.6%; 3-month momentum negative (-16.2%); rising volume on a downtrend (distribution, 2.33x avg). Currently 44.7% off its 52-week high. Score: -7/7.
CLBT is trading below its 200-day MA ($14.94) — a key warning sign the longer-term trend is under pressure. An RSI of 28.2 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -30.6% compares to +20.5% for SPY (trailed the market by 51.0%). The current 44.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.